ArticleThe Lancet. Rheumatology2020

Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial.

Athimalaipet V Ramanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.